Sarepta Therapeutics (SRPT) Net Income Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -115.33% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -73.01% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,228.66% |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | 173.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 173.96% |
| Dec 31, 2025 | -524.65% |
| Sep 30, 2025 | -635.47% |
| Jun 30, 2025 | 2,939.86% |
| Mar 31, 2025 | -1,337.99% |
| Dec 31, 2024 | -77.47% |
| Sep 30, 2024 | 182.09% |
| Jun 30, 2024 | 127.06% |
| Mar 31, 2024 | 107.00% |
| Dec 31, 2023 | -10.11% |
| Sep 30, 2023 | 84.12% |
| Jun 30, 2023 | 89.66% |
| Mar 31, 2023 | -392.03% |
| Dec 31, 2022 | 542.96% |
| Sep 30, 2022 | -435.35% |
| Jun 30, 2022 | -184.36% |
| Mar 31, 2022 | 37.20% |
| Dec 31, 2021 | 60.73% |
| Sep 30, 2021 | 75.50% |
| Jun 30, 2021 | 46.03% |
| Mar 31, 2021 | -856.15% |
| Dec 31, 2020 | 19.68% |
| Sep 30, 2020 | -55.55% |
| Jun 30, 2020 | 45.43% |
| Mar 31, 2020 | 77.18% |
| Dec 31, 2019 | -67.29% |
| Sep 30, 2019 | -65.36% |
| Jun 30, 2019 | -152.96% |
| Mar 31, 2019 | -116.73% |
| Dec 31, 2018 | -487.11% |
| Sep 30, 2018 | -60.04% |
| Jun 30, 2018 | -73.31% |
| Mar 31, 2018 | -142.05% |
| Dec 31, 2017 | 72.87% |
| Sep 30, 2017 | 15.88% |
| Jun 30, 2017 | -1.20% |
| Mar 31, 2017 | 240.69% |
| Dec 31, 2016 | -37.24% |
| Sep 30, 2016 | -9.62% |
| Jun 30, 2016 | -47.96% |
| Mar 31, 2016 | 3.38% |
| Dec 31, 2015 | -44.12% |
| Sep 30, 2015 | -53.71% |
| Jun 30, 2015 | -39.10% |
| Mar 31, 2015 | -146.26% |
| Dec 31, 2014 | -36.14% |
| Sep 30, 2014 | -35.40% |
| Jun 30, 2014 | -76.96% |
| Mar 31, 2014 | -65.51% |
| Dec 31, 2013 | -219.45% |
| Sep 30, 2013 | -263.70% |
| Jun 30, 2013 | -213.87% |
| Mar 31, 2013 | -123.93% |
| Dec 31, 2012 | -16.15% |
| Sep 30, 2012 | 38.24% |
| Jun 30, 2012 | 45.36% |
| Mar 31, 2012 | -24.57% |
| Dec 31, 2011 | -436.22% |
| Sep 30, 2011 | -198.03% |
| Jun 30, 2011 | -30.96% |